Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank0
3Y CAGR-55.3%
5Y CAGR-34.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-55.3%/yr
vs +75.5%/yr prior
5Y CAGR
-34.4%/yr
Recent deceleration
Acceleration
-130.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $6.21M | -70.1% |
| 2023 | $20.75M | -53.4% |
| 2022 | $44.58M | -36.1% |
| 2021 | $69.72M | +4.3% |
| 2020 | $66.84M | +30.5% |
| 2019 | $51.21M | +105.9% |
| 2018 | $24.87M | +238.7% |
| 2017 | $7.34M | - |